Vad

Moleac launches CognivAiD™, a novel targeted product for vascular dementia

Retrieved on: 
Monday, January 16, 2023

CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia.

Key Points: 
  • CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia.
  • SINGAPORE, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Moleac announced on 29th October 2022 the launch of CognivAiD™, the first-in-market specific product for Vascular Dementia (VaD).
  • David Picard, CEO of Moleac, commented on the launch: “Moleac focuses on neurology to help patients reconnect with their lives.
  • Vascular dementia, the second most common subtype of dementia after Alzheimer’s disease, accounts for 15-30% of all dementia cases 2 .

Berlin Heart Completes Post Approval Surveillance; Report Details Improved Outcomes for Pediatric Heart Failure Patients Supported with EXCOR® Pediatric

Retrieved on: 
Thursday, July 2, 2020

The final report submitted to the FDA confirmed the positive contemporary results of treating pediatric heart failure patients with the EXCOR Pediatric VAD System.

Key Points: 
  • The final report submitted to the FDA confirmed the positive contemporary results of treating pediatric heart failure patients with the EXCOR Pediatric VAD System.
  • In addition, the safety and efficacy of the EXCOR Pediatric VAD fulfilled all other defined study end points.
  • Since the PMA for the Berlin Heart EXCOR Pediatric VAD System was granted by the FDA, more than 270 patients have been supported with the device in North America.
  • The objective of this prospective surveillance was to demonstrate the continued safety and effectiveness of the Berlin Heart EXCOR Pediatric Ventricular Assist Device.

Global Ventricular Assist Device (VAD) Market 2019-2025: Analysis by Product, Type of Flow, Application, and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 20, 2019

The "Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global ventricular assist device market size is expected to reach USD 2,464.9 million by 2025, at a CAGR 11.4% over a forecast period.
  • Ventricular assist device (VAD) market is majorly driven by rising prevalence of heart failures, shortage of organ donors, and recent technological advancements improving the quality of lives of patients with weakened heart.
  • Increasing number of research activities and new product launches are some of the major factors contributing to the market growth.

The global ventricular assist device market size is expected to reach USD 2,464.9 million by 2025, at a CAGR 11.4% over a forecast period

Retrieved on: 
Monday, June 17, 2019

NEW YORK, June 17, 2019 /PRNewswire/ -- Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025

Key Points: 
  • NEW YORK, June 17, 2019 /PRNewswire/ -- Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025
    The global ventricular assist device market size is expected to reach USD 2,464.9 million by 2025, at a CAGR 11.4% over a forecast period.
  • Ventricular assist device (VAD) market is majorly driven by rising prevalence of heart failures, shortage of organ donors, and recent technological advancements improving the quality of lives of patients with weakened heart.
  • HeartMate 3 LVAD by Abbott and EXCOR Pediatric LVAD by Berlin Heart are some of the examples of technologically advanced products.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Global Artificial Heart Market 2019-2023 - Focus on Development of Non-Blood-Contacting VADs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 29, 2019

The artificial heart market will register a CAGR of almost 9% by 2023.

Key Points: 
  • The artificial heart market will register a CAGR of almost 9% by 2023.
  • Advances in VAD (ventricular assist device) technology will be a key factor driving the growth of the market.
  • Such technological advances and product launches are expected to increase the demand for VADs, which in turn, drives the market.
  • Hence, the high cost of artificial hearts and procedures are hampering the growth of the global artificial heart market.

Exclusive Group Further Advances Global VAD Reach with Acquisition of SecureWave in Israel

Retrieved on: 
Tuesday, February 19, 2019

Exclusive Group, the value-added services and technologies (VAST) group, today announced it is acquiring SecureWave, one of Israels leading independent cybersecurity VADs.

Key Points: 
  • Exclusive Group, the value-added services and technologies (VAST) group, today announced it is acquiring SecureWave, one of Israels leading independent cybersecurity VADs.
  • In SecureWave we feel we have identified a like-minded VAD business with a committed and successful team who understand value.
  • On behalf of SecureWaves staff and partner community, we are delighted to join Exclusive Group on its journey as the worlds biggest global specialist VAD in cyber and cloud, said Moran Gerassi, CEO at SecureWave.
  • Exclusive Group is building the worlds biggest specialist VAD in cybersecurity and cloud transformation.

Exclusive Group Acquires Canadian VAD To Expand Presence Across North America

Retrieved on: 
Thursday, February 7, 2019

Exclusive Group, the value-added services and technologies (VAST) group, today announced the acquisition of leading Canadian cybersecurity VAD, Fine Tec Canada, to complement its existing US presence and expand global coverage to the whole of North America.

Key Points: 
  • Exclusive Group, the value-added services and technologies (VAST) group, today announced the acquisition of leading Canadian cybersecurity VAD, Fine Tec Canada, to complement its existing US presence and expand global coverage to the whole of North America.
  • The deal coincides with the appointment of Exclusive Group veteran Laurent Daudr-Vignier as SVP North America to oversee and grow operations across the region.
  • Our success in North America to date has been critical to executing our global strategy, and our intention has always been to build on our US presence with the addition of a leading specialist VAD in the Canadian market, said Olivier Breittmayer, CEO at Exclusive Group.
  • Exclusive Group is building the worlds biggest specialist VAD in cybersecurity and cloud transformation.